United States of America

This page will review Illinois medical malpractice cases involving birth injuries. We will explain some relevant Illinois laws, review how birth injury lawsuits work in Illinois, and discuss the expected settlement amounts in Illinois birth injury lawsuits.

How to Project Illinois Birth Injury Settlement Amounts

One of the hardest things a birth injury lawyer must do is project settlement amounts for a family’s lawsuit. But you need to know what a settlement amount should be to advise the client on their settlement options. Determining the settlement amount in a birth injury lawsuit can be a challenging task for attorneys, as many factors can affect the final settlement amount. Birth injury cases can be particularly complex, and the amount of damages awarded can vary widely depending on the specific circumstances of the case.

With its new statute of limitations, California has become an epicenter for school sexual abuse lawsuits. A large percentage of landmark school sex abuse settlements are coming from California.

If you were sexually abused by a teacher, coach, counselor, administrator, volunteer, contractor, or another student, you may have a civil claim against not only the predator who abused you, but the school and other organizations.

So many victims do not bring claims because they think the bar is higher than it is. The biggest impediment we see is the assumption that you needed to report the crime at the time or even get a criminal conviction. Nothing could be further from the truth. You could still have a case if the sexual abuse was never reported to police, prosecutors declined to file charges, or the school insisted that it could not substantiate your complaint.

If you were the victim of sexual abuse or assault, either as a child or an adult, you may have the right to bring a civil lawsuit against the person who abused you and, in many cases, a school, church, company, treatment center, government agency, or other organization that failed to protect you.

That second part is where the real civil case is.

The abuser is responsible for the abuse. No question. But what did the adults around that person know? Were there earlier complaints? Did a school quietly move an employee instead of investigating? Did DCF have information that should have triggered intervention? Did an organization put its reputation ahead of the child it was supposed to protect?

This page looks at civil lawsuits for victims of sexual abuse at San Diego juvenile detention centers.

San Diego juvenile halls are at the center of a troubling investigation into allegations of sexual abuse and misconduct against minors who were detained at the facility. Survivors have come forward with reports of sexual exploitation, misconduct by staff members, and a pervasive culture of sexual abuse that was allegedly ignored or covered up by those in power. These allegations are part of a larger pattern of sexual abuse within the juvenile justice system, where vulnerable youth are too often subjected to harm by the very individuals entrusted with their care.

We think San Diego will be the next California juvenile hall sex abuse settlement domino to fall.  Our lawyers talk about this, and the San Diego juvenile hall settlement amounts we expect to see in these lawsuits, below.

If you were the victim of sexual abuse or assault in Seattle or anywhere in Washington, either as a child or an adult, you may have the right to bring a civil lawsuit. The lawsuit may name not only the abuser but also a school, facility, company, government agency, church, or other organization that enabled the abuse or failed to protect you. Our sex abuse attorneys help survivors hold these institutions accountable.

This page looks at sexual abuse lawsuits in Washington, including recent cases, settlement amounts, the statute of limitations, and what you actually have to prove to bring a claim.

Washington has also changed its statute of limitations for childhood sexual abuse. For qualifying abuse occurring on or after June 6, 2024, there is no civil statute of limitations. Older claims are different. We explain those rules below because, unfortunately, the answer for an older survivor is not nearly as simple.

Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas. On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.

Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, COPD, and a host of other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different and not one they could have expected.

Now, lawsuits allege that Regeneron and Sanofi failed to warn doctors and patients that cutaneous T-cell lymphoma, often called CTCL, can mimic eczema and that Dupixent may mask, accelerate, or delay diagnosis of an underlying lymphoma. Plaintiffs argue that patients with adult-onset, atypical, or treatment-resistant dermatitis should have been warned to rule out lymphoma before starting Dupixent and to stop and investigate if symptoms changed during treatment.

Our lawyers are reviewing hair relaxer cancer lawsuits on behalf of women throughout the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation now includes nearly 12,000 plaintiffs. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. No hair relaxer settlement has been announced, and no plaintiff has received a settlement payout through the federal MDL. The latest hair relaxer lawsuit update is that Judge Mary Rowland has lifted a discovery stay for a group of defendants after concluding that settlement discussions had not produced enough progress to justify keeping those cases frozen.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis, or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.

Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.

Continue reading

Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.

Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make many allegations. At their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families or give them a choice.

If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to participate in a class action lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.

This page is for women considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates, explain the litigation and settlement process, and offer our assessment of potential Depo-Provera settlement amounts.

Scientific research has found a strong association between prolonged use of injectable medroxyprogesterone acetate, the active drug in Depo-Provera, and intracranial meningioma. Women who received Depo-Provera injections and were later diagnosed with a meningioma are filing lawsuits alleging that Pfizer and related companies failed to provide an adequate warning.

Contact Information